Project Grant HT94252510979
Award Date 9/30/25
Completion Date 9/29/27
Dollars Obligated $576K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Tacoma, WA 98402, USA
Similar Awards
- This federal Project Grant award of $487,800.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research by The Geneva Foundation to define the cellular origins and molecular vulnerabilities of Notch-driven lymphomas. The project will run from October 1, 2025 to September 30, 2027 and is being conducted in Tacoma, Washington. The Geneva Foundation, a non-profit research organization, will lead this advanced biomedical research effort,...
- The Geneva Foundation received a $4,676,544 Project Grant award from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420) to develop and validate innate immunome-targeted therapies to create a pro-survival and organ-protective phenotype after hemorrhage at the point of injury. Specifically, the Foundation will investigate immunotherapy approaches for hemorrhage treatments using innate immunome-targeted therapies from July 1, 2023 to...
- The Geneva Foundation will receive $910,559 under a Cooperative Agreement awarded by the Department of the Army Medical Command on August 15, 2022. The funding supports a research project titled "In Vivo Imaging of Lymphatic Circulation: Measurement of Brain Interstitial Fluid Flow During Wake and Sleep with Ultra-High Performance MRI." The project aims to investigate medical solutions for the battlefield by transforming health care through innovative and impactful research, as part of...
- This $909,510 Project Grant award was made on May 1, 2025 by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to The Geneva Foundation, a non-profit medical research organization based in Tacoma, WA. The grant funding will support advanced biomedical research aimed at developing precision therapy approaches to eradicate brain metastatic breast cancer over the 3-year project period ending on April 30, 2028. The Geneva Foundation plans to...
- This federal Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) provides $1,065,392.00 to The Geneva Foundation to conduct research on "LOCAL SLEEP IN THE WAKING BRAIN: A NOVEL TARGET FOR COGNITIVE FATIGUE". The project period runs from June 1, 2024 to May 31, 2028. As a non-profit research organization, The Geneva Foundation will perform foundational biomedical research investigating innovative treatments for...
- This federal Project Grant award, in the amount of $2,198,698.00, was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to The Geneva Foundation. The award is for the project "EXTRACORPOREAL IMMUNOMODULATION TO REDUCE INFLAMMATION AFTER SEVERE BURNS, INHALATION INJURY, AND SEPTICEMIA," with a performance period from November 1, 2025 to October 31, 2028. The Geneva Foundation, a non-profit organization specializing in...
- The Defense Health Agency awarded a $410,000 Project Grant titled "Localized and Inflammation-Responsive Immunotherapy of VCA Rejection" to The Geneva Foundation, a 501(c)3 non-profit organization that supports medical research and education for the U.S. military. This grant is part of the "Military Medical Research and Development" program (CFDA 12.420), which funds basic, applied, and advanced biomedical research to transform healthcare for Service Members and the public...
- The Defense Health Agency awarded a $1,485,574 cooperative agreement to the Henry M. Jackson Foundation For The Advancement Of Military Medicine Inc. from September 30, 2022 to September 29, 2025 under the Military Medical Research and Development program. The award will support research into using quantitative pupillometry combined with blood biomarkers for the diagnosis and prognosis of mild traumatic brain injury. Dr. Bradley Dengler of the Geneva Foundation will conduct a prospective study...
- This Project Grant award, totaling $10,009,861.88, was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The award supports two primary activities: A randomized controlled multisite trial evaluating a portable near-infrared hematoma imager for the detection of intracranial hemorrhage in acute care settings. This trial will evaluate the efficacy and feasibility of this medical imaging device. A randomized controlled multisite trial...
- This federal Project Grant award, valued at $1,009,750.00, was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to The Geneva Foundation, a non-profit research organization based in Tacoma, Washington. The grant supports advanced biomedical research focused on the "Genomic and Functional Characterization of Chemoresistance in Small Cell Lung Cancer". The award period runs from August 1, 2025, to July 31, 2028. The Geneva...